Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QHU0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 179 | 183 | PF00656 | 0.432 |
CLV_NRD_NRD_1 | 272 | 274 | PF00675 | 0.308 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.402 |
CLV_NRD_NRD_1 | 335 | 337 | PF00675 | 0.246 |
CLV_PCSK_KEX2_1 | 272 | 274 | PF00082 | 0.335 |
CLV_PCSK_SKI1_1 | 250 | 254 | PF00082 | 0.277 |
CLV_PCSK_SKI1_1 | 286 | 290 | PF00082 | 0.402 |
CLV_PCSK_SKI1_1 | 381 | 385 | PF00082 | 0.261 |
DEG_SPOP_SBC_1 | 327 | 331 | PF00917 | 0.540 |
DOC_CKS1_1 | 104 | 109 | PF01111 | 0.445 |
DOC_USP7_MATH_1 | 261 | 265 | PF00917 | 0.525 |
DOC_USP7_MATH_1 | 327 | 331 | PF00917 | 0.540 |
DOC_USP7_UBL2_3 | 108 | 112 | PF12436 | 0.460 |
DOC_WW_Pin1_4 | 103 | 108 | PF00397 | 0.448 |
DOC_WW_Pin1_4 | 139 | 144 | PF00397 | 0.466 |
LIG_14-3-3_CanoR_1 | 114 | 122 | PF00244 | 0.446 |
LIG_14-3-3_CanoR_1 | 158 | 168 | PF00244 | 0.497 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.461 |
LIG_BRCT_BRCA1_1 | 329 | 333 | PF00533 | 0.540 |
LIG_Clathr_ClatBox_1 | 297 | 301 | PF01394 | 0.458 |
LIG_FHA_2 | 329 | 335 | PF00498 | 0.540 |
LIG_LIR_Gen_1 | 171 | 181 | PF02991 | 0.455 |
LIG_LIR_Gen_1 | 253 | 262 | PF02991 | 0.476 |
LIG_LIR_Nem_3 | 171 | 177 | PF02991 | 0.455 |
LIG_LIR_Nem_3 | 246 | 252 | PF02991 | 0.461 |
LIG_LIR_Nem_3 | 253 | 257 | PF02991 | 0.500 |
LIG_REV1ctd_RIR_1 | 246 | 254 | PF16727 | 0.398 |
LIG_SH2_CRK | 341 | 345 | PF00017 | 0.491 |
LIG_SH2_GRB2like | 221 | 224 | PF00017 | 0.526 |
LIG_SH2_SRC | 133 | 136 | PF00017 | 0.476 |
LIG_SH2_SRC | 93 | 96 | PF00017 | 0.559 |
LIG_SH2_STAP1 | 174 | 178 | PF00017 | 0.540 |
LIG_SH2_STAT5 | 10 | 13 | PF00017 | 0.361 |
LIG_SH2_STAT5 | 133 | 136 | PF00017 | 0.445 |
LIG_SH2_STAT5 | 205 | 208 | PF00017 | 0.468 |
LIG_SH2_STAT5 | 254 | 257 | PF00017 | 0.540 |
LIG_SH2_STAT5 | 312 | 315 | PF00017 | 0.445 |
LIG_SH3_2 | 140 | 145 | PF14604 | 0.460 |
LIG_SH3_3 | 134 | 140 | PF00018 | 0.475 |
LIG_SUMO_SIM_anti_2 | 16 | 23 | PF11976 | 0.427 |
LIG_SUMO_SIM_anti_2 | 165 | 171 | PF11976 | 0.488 |
LIG_SUMO_SIM_par_1 | 295 | 301 | PF11976 | 0.492 |
LIG_TYR_ITIM | 339 | 344 | PF00017 | 0.491 |
LIG_WRC_WIRS_1 | 254 | 259 | PF05994 | 0.429 |
LIG_WRC_WIRS_1 | 370 | 375 | PF05994 | 0.460 |
MOD_CDC14_SPxK_1 | 142 | 145 | PF00782 | 0.459 |
MOD_CDK_SPK_2 | 103 | 108 | PF00069 | 0.445 |
MOD_CDK_SPxK_1 | 103 | 109 | PF00069 | 0.491 |
MOD_CDK_SPxK_1 | 139 | 145 | PF00069 | 0.466 |
MOD_CK1_1 | 150 | 156 | PF00069 | 0.480 |
MOD_CK2_1 | 150 | 156 | PF00069 | 0.462 |
MOD_CK2_1 | 159 | 165 | PF00069 | 0.410 |
MOD_CK2_1 | 261 | 267 | PF00069 | 0.534 |
MOD_CK2_1 | 328 | 334 | PF00069 | 0.501 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.523 |
MOD_GlcNHglycan | 116 | 119 | PF01048 | 0.254 |
MOD_GlcNHglycan | 277 | 281 | PF01048 | 0.252 |
MOD_GlcNHglycan | 349 | 352 | PF01048 | 0.303 |
MOD_GlcNHglycan | 363 | 366 | PF01048 | 0.223 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.445 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.526 |
MOD_GSK3_1 | 16 | 23 | PF00069 | 0.455 |
MOD_GSK3_1 | 203 | 210 | PF00069 | 0.456 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.240 |
MOD_GSK3_1 | 96 | 103 | PF00069 | 0.445 |
MOD_N-GLC_1 | 203 | 208 | PF02516 | 0.288 |
MOD_N-GLC_1 | 38 | 43 | PF02516 | 0.245 |
MOD_NEK2_1 | 100 | 105 | PF00069 | 0.447 |
MOD_NEK2_1 | 149 | 154 | PF00069 | 0.472 |
MOD_NEK2_1 | 255 | 260 | PF00069 | 0.478 |
MOD_NEK2_1 | 276 | 281 | PF00069 | 0.511 |
MOD_PIKK_1 | 203 | 209 | PF00454 | 0.534 |
MOD_PKA_2 | 113 | 119 | PF00069 | 0.445 |
MOD_Plk_4 | 16 | 22 | PF00069 | 0.451 |
MOD_Plk_4 | 197 | 203 | PF00069 | 0.491 |
MOD_Plk_4 | 250 | 256 | PF00069 | 0.551 |
MOD_ProDKin_1 | 103 | 109 | PF00069 | 0.448 |
MOD_ProDKin_1 | 139 | 145 | PF00069 | 0.466 |
TRG_DiLeu_BaEn_2 | 355 | 361 | PF01217 | 0.476 |
TRG_ENDOCYTIC_2 | 122 | 125 | PF00928 | 0.445 |
TRG_ENDOCYTIC_2 | 174 | 177 | PF00928 | 0.445 |
TRG_ENDOCYTIC_2 | 254 | 257 | PF00928 | 0.476 |
TRG_ENDOCYTIC_2 | 312 | 315 | PF00928 | 0.445 |
TRG_ENDOCYTIC_2 | 341 | 344 | PF00928 | 0.491 |
TRG_ER_diArg_1 | 65 | 68 | PF00400 | 0.451 |
TRG_Pf-PMV_PEXEL_1 | 263 | 267 | PF00026 | 0.301 |
TRG_Pf-PMV_PEXEL_1 | 342 | 346 | PF00026 | 0.301 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILK4 | Leptomonas seymouri | 78% | 99% |
A0A1X0NMG9 | Trypanosomatidae | 46% | 90% |
A0A3S7WQQ4 | Leishmania donovani | 94% | 97% |
A0A422N2F9 | Trypanosoma rangeli | 57% | 99% |
A4H5R5 | Leishmania braziliensis | 86% | 97% |
A4HU05 | Leishmania infantum | 94% | 97% |
D0A9H0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 57% | 98% |
E9AMT5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 97% |
O17606 | Caenorhabditis elegans | 43% | 100% |
O84391 | Chlamydia trachomatis (strain D/UW-3/Cx) | 25% | 100% |
P40093 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 40% | 100% |
Q55G91 | Dictyostelium discoideum | 40% | 100% |
Q58DG1 | Bos taurus | 45% | 100% |
Q641W2 | Rattus norvegicus | 44% | 100% |
Q9HB07 | Homo sapiens | 44% | 100% |
Q9JK81 | Mus musculus | 43% | 100% |
Q9P7T6 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 39% | 100% |
Q9Z862 | Chlamydia pneumoniae | 24% | 100% |
V5D8M5 | Trypanosoma cruzi | 56% | 98% |